RLMD
Relmada Therapeutics, Inc.NASDAQHealthcare$6.99-1.29%ClosedMarket Cap: $512.6M
As of 2026-04-06
Insider Statistics (Q4 2025)
Purchases
13
Sales
0
Buy/Sell Ratio
0.00
Total Bought
$6.00
Total Sold
$0.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Tue Dec 16 | TRAVERSA SERGIO | director, officer: Chief Executive Officer | Buy | 27,500 | $4.12 | 1,300,000 |
| Tue Dec 16 | TRAVERSA SERGIO | director, officer: Chief Executive Officer | Sell | 1,198,000 | $4.06 | 1,198,000 |
| Tue Dec 16 | Shenouda Maged | officer: Chief Financial Officer | Sell | 828,000 | $4.06 | 828,000 |
| Tue Dec 16 | Shenouda Maged | officer: Chief Financial Officer | Buy | 11,665 | $4.12 | 800,000 |
| Tue Dec 16 | Ence Chuck | officer: CA and CO | Sell | 828,000 | $4.06 | 828,000 |
| Tue Dec 16 | Fedeli Fabiana | director | Sell | 164,000 | $4.06 | 164,000 |
| Tue Dec 16 | GLASSPOOL JOHN | director | Sell | 164,000 | $4.06 | 164,000 |
| Tue Dec 16 | Kelly Paul Edward | director, officer: COO | Sell | 828,000 | $4.06 | 828,000 |
| Tue Dec 16 | CASAMENTO CHARLES J | director | Sell | 164,000 | $4.06 | 164,000 |
| Thu Nov 06 | Shenouda Maged | officer: Chief Financial Officer | Buy | 500,000 | $2.20 | 788,335 |